Rayno Life Science Mid-day Movers: AMRI, ASTX, CPHD, ILMN, REGN

buy Maxalt on line buy modafinil uk next day delivery Markets Are Back To Fretting About Fiscal Cliff

Bernanke scolded Congress on the fiscal cliff and markets turned down. Despite a lackluster market down about 0.3% follow url there is a lot of green in biotech. Among the winners in the Rayno Life Science universe are:

Albany Molecular (AMRI $4.21) broke through to new highs up 43% YTD. Recent Q3 Results showed revenue up, positive cash flow and improved guidance.

Astex Pharmaceuticals (ASTX $2.47) rose over 10% on Phase 1/2 results of their MDS drug SG-110 novel hypomethylating drug. Results will be presented at the ASH on Dec 10.

Cepheid (CPHD $31.67) was up over 5% on volume over 600k on no particular news but recent upgrades and conference presentations.The stock hit a 2012 low of $28.12 last week.

Illumina (ILMN $50.3) hovered above $50 after recent news that it was bidding for Complete Genomics (GNOM) for $113M in cash.

Regeneron (REGN $174)  rocked on up 8.7% (118% YTD) and a 52 week high and encouraging news from the European Regulatory authority CHMP with potential approval of Zaltrap for combination therapy of colon cancer.

Also up among our portfolio winners is Biogen -Idec (BIIB) and the iShares NASDAQ ETF IBB back now to $135 after correcting to the $127 level recently.

, ,

No comments yet.

Leave a Reply